Healthcare

Ramsay Health Care Limited, listed as (ASX:RHC), operates in private hospital services, surgical facilities and specialist healthcare. The business has reported developments during 2026 concerning its operations, financial position and near-term priorities. On 21 October 2026, Ramsay Health Care Limited (ASX:RHC) was quoted at …

Sonic Healthcare Limited, listed as (ASX:SHL), operates in pathology, laboratory medicine and diagnostic imaging services. The business has reported developments during 2026 concerning its operations, financial position and near-term priorities. On 21 October 2026, Sonic Healthcare Limited (ASX:SHL) was quoted at AUD 18.76, with …

Cochlear Limited, listed as (ASX:COH), operates in implantable hearing systems and related sound processors. The business has reported developments during 2026 concerning its operations, financial position and near-term priorities. On 21 October 2026, Cochlear Limited (ASX:COH) was quoted at AUD 139.90, with a daily …

Telix Pharmaceuticals Limited (ASX:TLX) operates across its specialist market. Its commercial precision-medicine portfolio includes Illuccix and Gozellix for prostate cancer imaging. Manufacturing and distribution activities support clinical and commercial demand across several markets. Its business model creates exposure to customer demand, sector regulation and …

The Sydney-based company sells trophon equipment for high-level disinfection of ultrasound probes. The business also generates recurring income from disinfection consumables, accessories, service and replacement parts. Its product range includes trophon3 and the trophon2 Plus software upgrade, alongside technical support and probe-compatibility testing with …

The group offers magnetic resonance imaging, computed tomography, ultrasound, X-ray, mammography, nuclear medicine and other diagnostic services. Referrals come from medical practitioners, with examinations delivered by radiologists, sonographers and other clinical employees. Imaging supports diagnosis, treatment planning and ongoing management across a wide range …

Clarity designs targeted copper theranostics, which combine diagnostic imaging with related treatments aimed at the same biological target. Copper-64 is used in investigational positron emission tomography imaging agents, while copper-67 is being studied for targeted radiotherapy. Its principal prostate cancer asset, SAR-bisPSMA, is being …